Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

CYP2C8-Mediated Formation of a Human Disproportionate Metabolite of the Selective NaV1.7 Inhibitor DS-1971a, a Mixed Cytochrome P450 and Aldehyde Oxidase Substrate

Daigo Asano, Syoya Hamaue, Hamim Zahir, Hideyuki Shiozawa, Yumi Nishiya, Takako Kimura, Miho Kazui, Naotoshi Yamamura, Marie Ikeguchi, Takahiro Shibayama, Shin-ichi Inoue, Tsuyoshi Shinozuka, Toshiyuki Watanabe, Chizuko Yahara, Nobuaki Watanabe and Kouichi Yoshinari
Drug Metabolism and Disposition March 2022, 50 (3) 235-242; DOI: https://doi.org/10.1124/dmd.121.000665
Daigo Asano
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Syoya Hamaue
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamim Zahir
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideyuki Shiozawa
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yumi Nishiya
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takako Kimura
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miho Kazui
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naotoshi Yamamura
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Ikeguchi
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takahiro Shibayama
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shin-ichi Inoue
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsuyoshi Shinozuka
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiyuki Watanabe
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chizuko Yahara
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuaki Watanabe
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kouichi Yoshinari
Drug Metabolism and Pharmacokinetics Research Laboratories (D.A., H.S., Y.N., M.K., N.Y., Ta.S., S.I., C.Y., N.W.), Translational Science Department (M.I.), R&D Planning and Management Department (Ts.S.), and Medicinal Safety Research Laboratories (T.W.), Daiichi Sankyo Co., Ltd., Tokyo, Japan; Organic and Biomolecular Chemistry Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan (S.H., T.K.); Quantitative Clinical Pharmacology and Translational Sciences, Daiichi Sankyo, Inc., Basking Ridge, New Jersey (H.Z.); and Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 50 (3)
Drug Metabolism and Disposition
Vol. 50, Issue 3
1 Mar 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CYP2C8-Mediated Formation of a Human Disproportionate Metabolite of the Selective NaV1.7 Inhibitor DS-1971a, a Mixed Cytochrome P450 and Aldehyde Oxidase Substrate
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Mechanism of Human Disproportionate Metabolite Formation

Daigo Asano, Syoya Hamaue, Hamim Zahir, Hideyuki Shiozawa, Yumi Nishiya, Takako Kimura, Miho Kazui, Naotoshi Yamamura, Marie Ikeguchi, Takahiro Shibayama, Shin-ichi Inoue, Tsuyoshi Shinozuka, Toshiyuki Watanabe, Chizuko Yahara, Nobuaki Watanabe and Kouichi Yoshinari
Drug Metabolism and Disposition March 1, 2022, 50 (3) 235-242; DOI: https://doi.org/10.1124/dmd.121.000665

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Mechanism of Human Disproportionate Metabolite Formation

Daigo Asano, Syoya Hamaue, Hamim Zahir, Hideyuki Shiozawa, Yumi Nishiya, Takako Kimura, Miho Kazui, Naotoshi Yamamura, Marie Ikeguchi, Takahiro Shibayama, Shin-ichi Inoue, Tsuyoshi Shinozuka, Toshiyuki Watanabe, Chizuko Yahara, Nobuaki Watanabe and Kouichi Yoshinari
Drug Metabolism and Disposition March 1, 2022, 50 (3) 235-242; DOI: https://doi.org/10.1124/dmd.121.000665
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Author Contributions
    • Acknowledgments
    • Footnotes
    • ABBREVIATIONS
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME Properties of Abrocitinib
  • MSCs Pharmacokinetics under liver diseases
  • In Vitro-In Vivo Extrapolation Using Empirical Scaling
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics